Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
A2585 MG-132136 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A2614 Bortezomib (PS-341)59 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A8627 Bafilomycin A135 CitationSummary: V-ATPases inhibitor -
A2571 Pepstatin A10 CitationTarget: Cathepsins|Renin|HIV proteases|PepsinsSummary: aspartic proteases inhibitor -
A8212 PR-6194 CitationTarget: Deubiquitinating enzymes (DUBs)Summary: Deubiquitylating enzymes (DBUs) inhibitor -
A8487 Nocodazole8 CitationTarget: Microtubules/TubulinsSummary: microtubule polymerization inhibitor -
A4393 Paclitaxel (Taxol)30 CitationTarget: Microtubules/TubulinsSummary: microtubule depolymerization inhibitor -
A8544 Wortmannin12 CitationSummary: PI3K inhibitor,selective and irreversible -
A8883 SAR40534 CitationSummary: Selective ATP-competitive inhibitor of Vps34 -
A1903 E 64d10 CitationSummary: Cysteine protease inhibitor
